RSCI 533 Safety Evaluation during Drug Development
Units: 3 Safety pharmacology/toxicology requirements mandated by FDA and other regulatory agencies to move a new chemical entity from discovery stage to market approval. Instruction Mode: Lecture Grading Option: Letter
You must be logged in to post a comment.